Evidence map›Paper›PMID 37358244›Full record

ArticleACS nano2023

Remote Activation of Enzyme Nanohybrids for Cancer Prodrug Therapy Controlled by Magnetic Heating.

Beatriz Torres-Herrero, Ilaria Armenia, Maria Alleva, Laura Asín, Sonali Correa, Cecilia Ortiz, Yilian Fernández-Afonso, Lucía Gutiérrez, Jesús M de la Fuente, Lorena Betancor and 1 more

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Magnetic nanoparticles as promising materials for the future of medicine.Journal of materials science. Materials in medicine · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Beatriz Torres-HerreroInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID 0000-0003-4648-8972
Ilaria ArmeniaInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID 0000-0002-2854-2907
Maria AllevaInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID 0000-0002-4261-9480
Laura AsínCentro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid 28029, Spain.ORCID 0000-0003-0641-3407
Sonali CorreaLaboratorio de Biotecnología, Universidad ORT Uruguay, Montevideo, 11100, Uruguay.ORCID 0009-0006-7458-3108
Cecilia OrtizLaboratorio de Biotecnología, Universidad ORT Uruguay, Montevideo, 11100, Uruguay.
Yilian Fernández-AfonsoInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID 0000-0002-0970-1917
Lucía GutiérrezInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID 0000-0003-2366-3598
Jesús M de la FuenteInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID 0000-0003-1081-8482
Lorena BetancorLaboratorio de Biotecnología, Universidad ORT Uruguay, Montevideo, 11100, Uruguay.ORCID 0000-0002-0569-0499
Valeria GrazúInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID 0000-0001-6170-4237
Universidad de Zaragoza · ESUniversidad ORT Uruguay · UYBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we have developed nanohybrids (nHs) to remotely activate a therapeutic enzyme for its use in Directed Enzyme Prodrug Therapy (DEPT). The coencapsulation of magnetic nanoparticles (MNPs) with horseradish peroxidase (HRP) using biomimetic silica as an entrapment matrix was optimized to obtain nanosized hybrids (∼150 nm) for remote activation of the therapeutic enzyme. HRP converts indole-3-acetic acid (3IAA) into peroxylated radicals, whereas MNPs respond to alternating magnetic fields (AMFs) becoming local hotspots. The AMF application triggered an increase in the bioconversion rate of HRP matching the activity displayed at the optimal temperature of the nHs (

Indexed as

NanoparticlesNeoplasmsProdrugsAnimalsHeatingHumansMagnetic FieldsMagnetic PhenomenaSilicon DioxideProdrugsSilicon Dioxidebiomimetic silicaenzyme prodrug therapymagnetic heatingmagnetic nanoparticlesnanoactuationnanohybridremote enzyme activation

Identifiers

PMID37358244
PMCPMC10339790
OpenAlexW4382011252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.